CARMEN HUERTA: Open Payments
NPI 1871910950 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,923 in 195 payments from 18 companies in 2025. Trend: 2023 $2,189 · 2024 $3,864 · 2025 $3,923
Food & beverage: $3,835Education: $88
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 47 | $930 |
| Galderma Laboratories, L.P. | 24 | $588 |
| Incyte Corporation | 31 | $398 |
| Amgen Inc. | 19 | $336 |
| Regeneron Healthcare Solutions, Inc. | 12 | $335 |
| ABBVIE INC. | 16 | $229 |
| Arcutis Biotherapeutics, Inc. | 9 | $207 |
| Novartis Pharmaceuticals Corporation | 9 | $198 |
| GENZYME CORPORATION | 7 | $179 |
| UCB, Inc. | 7 | $139 |
Products named: ADBRY, NEMLUVIO, DUPIXENT, OPZELURA, OTEZLA, Zoryve, SKYRIZI, COSENTYX.
Industry payments across CA — which companies pay providers there.
